107 related articles for article (PubMed ID: 30463828)
1. Clinical research on therapeutic effect of combined application of lobaplatin and irinotecan in treating recurrant small cell lung cancer.
Zhang H; Zhang Y; Wang C; Fang S; Xu B; Wang C; Wu J; Liu D
Pak J Pharm Sci; 2018 Sep; 31(5(Special)):2295-2298. PubMed ID: 30463828
[TBL] [Abstract][Full Text] [Related]
2. Irinotecan as a second-line chemotherapy for small cell lung cancer: a systemic analysis.
Zhang MQ; Lin X; Li Y; Lu S
Asian Pac J Cancer Prev; 2015; 16(5):1993-5. PubMed ID: 25773800
[TBL] [Abstract][Full Text] [Related]
3. Retrospective study of the efficacy and toxicity of lobaplatin-etoposide chemotherapy in small cell lung cancer.
Gu L; Zhong D; Yu T; Tang P; Meng F; Qin Q
Thorac Cancer; 2019 Feb; 10(2):226-233. PubMed ID: 30600898
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of imatinib maintenance therapy after irinotecan and cisplatin in patients with c-Kit-positive, extensive-stage small-cell lung cancer.
Schneider BJ; Kalemkerian GP; Ramnath N; Kraut MJ; Wozniak AJ; Worden FP; Ruckdeschel JC; Zhang X; Chen W; Gadgeel SM
Clin Lung Cancer; 2010 Jul; 11(4):223-7. PubMed ID: 20630823
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of irinotecan plus nedaplatin (INP) in treating patients with extensive stage small cell lung cancer.
Li C; Huang XE; Li Y
Asian Pac J Cancer Prev; 2011; 12(2):487-90. PubMed ID: 21545218
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of lobaplatin plus S-1 and the predictive value of circulating tumor cell in patients with advanced gastric cancer].
Feng Q; Zhao JR; Zhang AX; Li SL
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):696-702. PubMed ID: 30293397
[No Abstract] [Full Text] [Related]
7. Randomized phase II study of maintenance irinotecan therapy versus observation following induction chemotherapy with irinotecan and cisplatin in extensive disease small cell lung cancer.
Han JY; Kim HT; Lim KY; Yoon SJ; Lee DH; Lee JS
J Thorac Oncol; 2008 Sep; 3(9):1039-45. PubMed ID: 18758308
[TBL] [Abstract][Full Text] [Related]
8. Weekly irinotecan combined with carboplatin for patients with small-cell lung cancer: A phase I study.
Ishimoto O; Sugawara S; Inoue A; Maemondo M; Nukiwa T
Respir Investig; 2015 Jul; 53(4):156-60. PubMed ID: 26100175
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer.
Murakami S; Saito H; Kondo T; Ito H; Oshita F; Yamada K
Cancer Chemother Pharmacol; 2018 Jan; 81(1):81-87. PubMed ID: 29116379
[TBL] [Abstract][Full Text] [Related]
10. Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial.
Goto K; Ohe Y; Shibata T; Seto T; Takahashi T; Nakagawa K; Tanaka H; Takeda K; Nishio M; Mori K; Satouchi M; Hida T; Yoshimura N; Kozuki T; Imamura F; Kiura K; Okamoto H; Sawa T; Tamura T;
Lancet Oncol; 2016 Aug; 17(8):1147-1157. PubMed ID: 27312053
[TBL] [Abstract][Full Text] [Related]
11. Intrapleural combination therapy with lobaplatin and erythromycin for non-small cell lung cancer-mediated malignant pleural effusion.
Xu L; Wang B; Gao M; Zhang Y; Qi Q; Li T; Li C; Wang A; Li Y
Thorac Cancer; 2018 Aug; 9(8):950-955. PubMed ID: 29917319
[TBL] [Abstract][Full Text] [Related]
12. Low-dose irinotecan as a second-line chemotherapy for recurrent small cell lung cancer.
Morise M; Niho S; Umemura S; Matsumoto S; Yoh K; Goto K; Ohmatsu H; Ohe Y
Jpn J Clin Oncol; 2014 Sep; 44(9):846-51. PubMed ID: 25057092
[TBL] [Abstract][Full Text] [Related]
13. A Randomized Controlled Trial Comparing Clinical Outcomes and Toxicity of Lobaplatin- Versus Cisplatin-Based Concurrent Chemotherapy Plus Radiotherapy and High-Dose-Rate Brachytherapy for FIGO Stage II and III Cervical Cancer.
Wang JQ; Wang T; Shi F; Yang YY; Su J; Chai YL; Liu Z
Asian Pac J Cancer Prev; 2015; 16(14):5957-61. PubMed ID: 26320479
[TBL] [Abstract][Full Text] [Related]
14. Radioactive seed implantation and lobaplatin chemotherapy are safe and effective in treating patients with advanced lung cancer.
Li JR; Sun Y; Liu L
Asian Pac J Cancer Prev; 2015; 16(9):4003-6. PubMed ID: 25987076
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of Loubo® (Lobaplatin) and pemetrexed for patients with metastatic breast cancer not responding to anthracycline or taxanes.
Deng QQ; Huang XE; Ye LH; Lu YY; Liang Y; Xiang J
Asian Pac J Cancer Prev; 2013; 14(1):413-7. PubMed ID: 23534764
[TBL] [Abstract][Full Text] [Related]
16. [Efficiency and adverse effects of the effective therapy applying etoposide + cisplatin and its subsequent maintenance therapy with different durations in patients with small cell lung cancer].
Yang CL; Ma LX; Sun SY; Cui HX; Li ZL; Cheng Y
Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):454-9. PubMed ID: 27346404
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer.
Spigel DR; Greco FA; Zubkus JD; Murphy PB; Saez RA; Farley C; Yardley DA; Burris HA; Hainsworth JD
J Thorac Oncol; 2009 Dec; 4(12):1555-60. PubMed ID: 19875975
[TBL] [Abstract][Full Text] [Related]
18. An open-label, single-arm phase II clinical study of docetaxel plus lobaplatin for Chinese patients with pulmonary and hepatic metastasis of nasopharyngeal carcinoma.
Zhang S; Chen J; Yang S; Lin S
Anticancer Drugs; 2016 Aug; 27(7):685-8. PubMed ID: 27088576
[TBL] [Abstract][Full Text] [Related]
19. Clinical Study on Lobaplatin Combined with 5-Fu and Concurrent Radiotherapy in Treating Patients with Inoperable Esophageal Cancer.
Jia XJ; Huang JZ
Asian Pac J Cancer Prev; 2015; 16(15):6595-7. PubMed ID: 26434880
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of irinotecan combined with nedaplatin in the treatment of small cell lung cancer.
Fu J; Fang S; Wen Y; Wang Y; Yin X; Wang D
J BUON; 2020; 25(4):1707-1713. PubMed ID: 33099904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
